Figure 2: Impact of treatment with intravenous ascorbic acid on serum cf-DNA levels.
(Serum cf-DNA levels of patients in the placebo (?), Lo (50mg/ml, ) and Hi (200mg/ml, Δ) groups are indicated. Patients in the placebo group exhibited highest levels of cf-DNA for up to 72 hours. Although serum cf-DNA levels were lower in both treatment arms, these data did not reach statistical significance (p>0.05, ANOVA). Data are expressed as mean ± SE.)